InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-8.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Winkeljohann, Prof. Dr. Norbert, Supervisory board. Director active across 1 company, notably Bayer Aktiengesellschaft. In total, 2 disclosures have been logged. History available since 5 March 2026. The latest transaction was filed on 5 March 2026 (Buy). Regulator: BaFin. All data is free.
Companies and markets linked to Winkeljohann, Prof. Dr. Norbert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
2,671.093 股@ €37.430.0003% mcap50.0% 占其流量ShareXetraISIN DE000BAY0017BAFIN:40001030
2,671.093 股@ €37.430.0003% mcap50.0% 占其流量ShareXetraISIN DE000BAY0017BAFIN:40001030-c4c1f85e3cb5
2 条申报中的 2 条
About Winkeljohann, Prof. Dr. Norbert
Prof. Dr. Norbert Winkeljohann is a member of the Supervisory Board at Bayer Aktiengesellschaft. He participates in the governance of the company and the oversight of its activities. His experience in the pharmaceutical sector allows him to provide strategic insights and contribute to important decision-making. His commitment to operational excellence is an asset for Bayer.
